Technical Analysis for LEGN - Legend Biotech Corporation
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 45.14 | -0.35% | -0.16 |
LEGN closed down 0.35 percent on Monday, April 29, 2024, on approximately normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: May 13
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
180 Bearish Setup | Bearish Swing Setup | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Slingshot Bearish | Bearish Swing Setup | -0.35% | |
Bullish Engulfing | Bullish | -0.35% | |
NR7 | Range Contraction | -0.35% | |
NR7-2 | Range Contraction | -0.35% | |
Narrow Range Bar | Range Contraction | -0.35% | |
Wide Bands | Range Expansion | -0.35% | |
Oversold Stochastic | Weakness | -0.35% |
Alert | Time |
---|---|
60 Minute Opening Range Breakdown | about 15 hours ago |
Possible NR7 | about 15 hours ago |
Up 2% | about 19 hours ago |
Rose Above Previous Day's High | about 20 hours ago |
Up 1% | about 20 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/13/2024
Legend Biotech Corporation develops cell therapy solutions for cancer patients. The company was founded in 2014 and is based in Cayman Islands. The company operates as a subsidiary of Genscript Biotech Corporation.
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Life Sciences Cell Therapy Genscript Biotech Tax Investigation
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Life Sciences Cell Therapy Genscript Biotech Tax Investigation
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 77.32 |
52 Week Low | 44.06 |
Average Volume | 1,044,484 |
200-Day Moving Average | 62.82 |
50-Day Moving Average | 57.84 |
20-Day Moving Average | 50.80 |
10-Day Moving Average | 46.68 |
Average True Range | 2.13 |
RSI (14) | 26.47 |
ADX | 33.9 |
+DI | 15.37 |
-DI | 26.46 |
Chandelier Exit (Long, 3 ATRs) | 51.24 |
Chandelier Exit (Short, 3 ATRs) | 50.46 |
Upper Bollinger Bands | 59.63 |
Lower Bollinger Band | 41.97 |
Percent B (%b) | 0.18 |
BandWidth | 34.76 |
MACD Line | -3.72 |
MACD Signal Line | -3.35 |
MACD Histogram | -0.3665 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 47.26 | ||||
Resistance 3 (R3) | 47.47 | 46.97 | 46.91 | ||
Resistance 2 (R2) | 46.97 | 46.43 | 46.87 | 46.79 | |
Resistance 1 (R1) | 46.06 | 46.10 | 45.81 | 45.85 | 46.67 |
Pivot Point | 45.56 | 45.56 | 45.43 | 45.45 | 45.56 |
Support 1 (S1) | 44.64 | 45.01 | 44.39 | 44.43 | 43.61 |
Support 2 (S2) | 44.14 | 44.68 | 44.04 | 43.49 | |
Support 3 (S3) | 43.23 | 44.14 | 43.37 | ||
Support 4 (S4) | 43.02 |